According to Mediclin's latest financial reports the company has a price-to-book ratio of 0.191942.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 0.5053 | -23.9% |
2023-12-31 | 0.6639 | -18.73% |
2022-12-31 | 0.8169 | -19.7% |
2021-12-31 | 1.02 | -2.38% |
2020-12-31 | 1.04 | -18.74% |
2019-12-31 | 1.28 | -10.13% |
2018-12-31 | 1.43 | -10.95% |
2017-12-31 | 1.60 | 4.35% |
2016-12-31 | 1.54 | 31.67% |
2015-12-31 | 1.17 | 6.78% |
2014-12-31 | 1.09 | -18.52% |
2013-12-31 | 1.34 | 6.78% |
2012-12-31 | 1.26 | 14.74% |
2011-12-31 | 1.09 | -12.17% |
2010-12-31 | 1.25 | 36.57% |
2009-12-31 | 0.9122 |